Artal Group S.A. - Q3 2015 holdings

$4.48 Billion is the total value of Artal Group S.A.'s 77 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 0.0% .

 Value Shares↓ Weighting
LXRX  LEXICON PHARMACEUTICALS INC$617,743,000
+33.4%
57,517,9780.0%13.80%
-30.7%
WW  WEIGHT WATCHERS INTL INC NEW$187,848,000
+31.5%
29,443,3000.0%4.20%
-31.7%
WMT  WAL-MART STORES INCcall$107,959,000
-8.6%
1,665,0000.0%2.41%
-52.5%
GE  GENERAL ELECTRIC COcall$50,440,000
-5.1%
2,000,0000.0%1.13%
-50.7%
AXP  AMERICAN EXPRESS COcall$33,359,000
-4.6%
450,0000.0%0.74%
-50.5%
GM  GENERAL MTRS COcall$30,020,000
-9.9%
1,000,0000.0%0.67%
-53.2%
QCOM  QUALCOMM INCcall$26,865,000
-14.2%
500,0000.0%0.60%
-55.5%
TEVA  TEVA PHARMACEUTICAL INDS LTDcall$25,407,000
-4.5%
450,0000.0%0.57%
-50.4%
MRK  MERCK & CO INC NEWcall$24,695,000
-13.2%
500,0000.0%0.55%
-54.9%
MCD  MCDONALDS CORPcall$19,706,000
+3.6%
200,0000.0%0.44%
-46.2%
ARRY  ARRAY BIOPHARMA INC$16,918,000
-36.8%
3,710,0000.0%0.38%
-67.2%
ISIS  ISIS PHARMACEUTICALS INC$16,168,000
-29.8%
400,0000.0%0.36%
-63.6%
CCI  CROWN CASTLE INTL CORP NEWcall$15,774,000
-1.8%
200,0000.0%0.35%
-49.1%
BAC  BANK AMER CORP$15,580,000
-8.5%
1,000,0000.0%0.35%
-52.5%
MU  MICRON TECHNOLOGY INCcall$14,980,000
-20.5%
1,000,0000.0%0.34%
-58.7%
GM  GENERAL MTRS CO$13,509,000
-9.9%
450,0000.0%0.30%
-53.3%
CCXI  CHEMOCENTRYX INC$5,445,000
-26.5%
900,0000.0%0.12%
-61.8%
JMEI  JUMEI INTL HLDG LTDsponsored adr$4,935,000
-56.8%
500,0000.0%0.11%
-77.6%
BTX  BIOTIME INC$3,846,000
-17.4%
1,282,0500.0%0.09%
-57.0%
CLLS  CELLECTIS S Asponsored ads$3,295,000
-26.9%
125,0000.0%0.07%
-61.9%
IRWD  IRONWOOD PHARMACEUTICALS INC$2,260,000
-13.6%
216,8790.0%0.05%
-55.8%
PARNF  PARNELL PHARMACEUT HLDGS LTD$1,720,000
-30.5%
500,0000.0%0.04%
-64.5%
ARRY  ARRAY BIOPHARMA INCcall$1,368,000
-36.8%
300,0000.0%0.03%
-66.7%
CERE  CERES INC$1,106,000
-44.6%
1,024,0200.0%0.02%
-70.9%
XOMA  XOMA CORP DELcall$301,000
-80.6%
400,0000.0%0.01%
-89.6%
CLCD  COLUCID PHARMACEUTICALS INC$22,000
-56.0%
5,5750.0%0.00%
-100.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AGENUS INC42Q3 20231.9%
IRONWOOD PHARMACEUTICALS INC42Q3 20230.3%
ALNYLAM PHARMACEUTICALS INC37Q3 20235.1%
LEXICON PHARMACEUTICALS INC34Q3 202320.6%
AMICUS THERAPEUTICS INC30Q3 20232.7%
BEIGENE LTD28Q3 20237.4%
BK OF AMERICA CORP28Q1 20214.3%
SAGE THERAPEUTICS INC28Q2 20231.9%
AGIOS PHARMACEUTICALS INC28Q2 20201.1%
NEKTAR THERAPEUTICS27Q2 20201.3%

View Artal Group S.A.'s complete holdings history.

Latest significant ownerships (13-D/G)
Artal Group S.A. Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
WEIGHT WATCHERS INTERNATIONAL INCFebruary 13, 201529,443,30051.9%

View Artal Group S.A.'s complete significant-ownership history.

Latest filings
TypeFiled
42024-03-25
42024-03-13
42024-02-29
13F-HR2024-02-09
13F-HR2023-11-13
42023-10-16
13F-HR2023-08-11
42023-06-22
32023-06-15
42023-06-05

View Artal Group S.A.'s complete filings history.

Compare quarters

Export Artal Group S.A.'s holdings